Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $45.4400 (0.09%) ($45.0700 - $46.0100) on Tue. Apr. 25, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.29% (three month average) | RSI | 85 | Latest Price | $45.4400(0.09%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 1.2% a day on average for past five trading days. | Weekly Trend | BAX advances 3.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) ARKG(22%) XLRE(22%) XLV(20%) ARKK(19%) IWD(19%) | Factors Impacting BAX price | BAX will decline at least -1.145% in a week (0% probabilities). EDOC(-26%) VXX(-18%) GLD(-15%) VIXM(-12%) SMH(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.145% (StdDev 2.29%) | Hourly BBV | 0.2 () | Intraday Trend | 0.8% | | | |
|
5 Day Moving Average | $44.6(1.88%) | 10 Day Moving Average | $43.83(3.67%) | 20 Day Moving Average | $42.56(6.77%) | To recent high | -3.3% | To recent low | 20.9% | Market Cap | $23.183b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |